San Francisco, Sep 24 The
global small
animal imaging (In-Vivo) market size is expected to reach 2.7
billion by 2022, according to a new report by Grand View Research, Inc.,
progressing at a CAGR of 9.0% during the forecast period. Rising number of
medical conditions requiring precise research for development of treatment options
is anticipated to stoke the demand for small animal imaging over the forecast
period.
Importance of these devices in applications such as defining mechanism
of action, drug receptor targeting, and epigenetic research studies are
projected to provide substantial growth for the market. Some of the major
drivers of small animal imaging (in-vivo) market are technical innovations such
as high-resolution MRI with other modalities, growing number of research and
pharmaceutical organizations, increasing investments of CROs in pre-clinical
studies, and rising adoption of multi-functional pre-clinical imaging.
Browse full research report on Small Animal Imaging (In-Vivo) Market: www.grandviewresearch.com/industry-analysis/small-animal-imaging-in-vivo-market
Further key findings from the report suggest:
- Optical
imaging was the largest segment in 2014 owing to rapid and easy operations
and relatively cost-effective in comparison to other devices
- Micro-MRI
technology is anticipated to be the fastest growing segment over the
forecast period due varied applications during anatomical and functional
analysis in developing mouse embryos and neonates
- In 2014,
bio-distribution and monitoring the treatment response dominated the
market in terms of revenue
- The cancer
cell detection segment is expected to show substantial growth due to the
increasing prevalence of cancer and rising government initiatives for
cancer diagnostics research
- North America
was the largest region in terms of revenue in 2016. Vast pre-clinical
research, increasing demand for rapid and advanced methods, established
healthcare infrastructure, and favorable platform for R&D pertaining
to technological advancements are the key factors driving the regional
market
- Europe was
the second largest region in 2014, due to a large number of clinical
research and pharmaceutical organizations and diagnostic device
manufacturers
- Asia Pacific
is projected to be the fastest growing region over the forecast period
owing to increasing clinical research activities, rising base of target
population, and emerging economies
- Some of the
key players are Promega Corporation, Inc.; Miltenyi Biotec GmbH; Life
Technologies Corporation; FujiFilm Holding Corporation; Siemens AG; Thermo
Fisher Scientific; Bruker Corporation; PerkinElmer Inc.; and Aspect
Imaging Ltd.
Browse more reports of this category
by Grand View Research: https://www.grandviewresearch.com/industry/healthcare
Grand View Research has segmented the global small animal imaging (in
vivo) market on the basis of technology, application, and region:
Small Animal Imaging (In-vivo) Technology Outlook (Revenue, USD
Million, 2012 - 2022)
- Micro-magnetic
resonance imaging
- Optical
imaging
- Nuclear
imaging
- Other imaging
modalities
Small Animal Imaging (In-vivo) Application Outlook (Revenue, USD
Million, 2012 - 2022)
- Monitoring
treatment response
- Bio-distribution
- Cancer cell
detection
- Biomarkers
- Longitudinal
studies
- Epigenetics
Small Animal Imaging (In-vivo) Regional Outlook (Revenue, USD
Million, 2012 - 2022)
- North America
- Europe
- Asia Pacific
- RoW
Browse press release of this report
by Grand View Research: www.grandviewresearch.com/press-release/global-small-animal-imaging-in-vivo-market
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For more information:
www.grandviewresearch.com
No comments:
Post a Comment